We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Failure to Destroy Toxic Protein Contributes to Progression of Huntington’s Disease
News   Jul 23, 2013

Gladstone-led study also finds target that boosts protein clearance, prolongs cell life.

READ MORE

ReNeuron Announces £33 Million Financing Package
News   Jul 22, 2013

Placing to raise up to £25.35 million, grant package of £7.8 million from Welsh Government and Notice of General Meeting.

READ MORE

EnVivo Pharmaceuticals Announces Appointment of President and Chief Executive Officer
News   Jul 12, 2013

Industry leader to direct company growth, commercialization of phase 3 programs in Alzheimer’s disease and schizophrenia, and expansion of diverse CNS pipeline.

READ MORE

Brain-Penetrating Particle Attacks Deadly Tumors
News   Jul 03, 2013

Researchers have shown that a new approach extends the lives of laboratory animals and are preparing to seek government approval for a human clinical trial.

READ MORE

Drug Improves Cognitive Function in Mouse Model of Down Syndrome
News   Jul 03, 2013

The drug, an asthma medication called formoterol, strengthened nerve connections in the hippocampus.

READ MORE

Protein Linked to Cognitive Decline in Alzheimer’s Identified
News   Jun 26, 2013

Findings highlight potential therapeutic targets.

READ MORE

Psychiatric Disorders Linked to a Protein Involved in the Formation of Long-Term Memories
News   Jun 25, 2013

Researchers have discovered a pathway by which the brain controls a molecule critical to forming long-term memories and connected with bipolar disorder and schizophrenia.

READ MORE

PsychoGenics and Sunovion Pharmaceuticals Inc. Expand Partnership
News   Jun 19, 2013

Companies announced that they have expanded the scope of their CNS drug discovery partnership and extended the agreement for another two years.

READ MORE

Yale Research Projects Exploring New Uses for Failed Drugs get NIH Funding
News   Jun 19, 2013

Two Yale School of Medicine research programs are among nine nationally to receive grants under a new federal program.

READ MORE

A Diabetes Drug, a Promising Treatment for Neurodegenerative Disease
News   Jun 11, 2013

Pioglitazone slows neurodegeneration and impaired locomotor system affected by X-linked adrenoleukodystrophy.

READ MORE